340B Drug Pricing Program
The Department of Health and Human Services’ Health Resources and Services Administration Oct. 1 announced approval of 10 drug companies to participate in the 340B Rebate Model Pilot Program.
The Centers for Medicare & Medicaid Services’ 340B Part D claims data repository became available Oct. 1 for voluntary data submissions.
AHA, others file Amicus Brief supporting hospital in challenge to Lilly 340B policy.
he AHA today submitted comments on the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act).
AHA comments on the bipartisan leadership in introducing the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act).
The AHA Sept. 23 submitted comments on the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act).
The AHA today told the CMS that a proposal included in the agency’s calendar year 2027 physician fee schedule proposed rule to make reporting mandatory as of Jan. 1, 2027, significantly understates the time, resources and complexity required for hospitals to comply.
A side-by-side comparison of each proposal and how each bill would address key program components.
As policymakers continue to discuss healthcare legislation, the AHA has developed several new resources to help hospitals and other stakeholders understand the proposals and their potential impact.
The Health Resources and Services Administration’s Office of Pharmacy Affairs Sept. 8 released information on the 340B Office of Pharmacy Affairs Information System Paperwork Reduction Act forms.